Title:
【発明の名称】医 薬
Document Type and Number:
Japanese Patent JP3026841
Kind Code:
B2
Abstract:
A pharmaceutical formulation comprising (i) one or more particulate medicaments, and (ii) 1,1,1,2-tetrafuoroethane as propellant, which formulation contains less than 0.0001% w/w surfactant based upon the weight of medicament, particulate medicament being present in an amount from 00005 to 5% w/w relative to the total weight of the formulation and having a particle size of less than 100 micrions, with the proviso that said medicament is other than salmeterol, salbutamol, fluticasone propionate, beclomethasone dipropionate or a physiologically acceptable salt or solvate thereof and with the proviso that when said formulation consists of betamethasone, ergotamine tartrate or sodium cromoglycate and 1,1,1,2-tetrafluoroethane the weight to weight ratio of medicament to propellant is other than 69:7900 or 0.866% w/w.
Inventors:
Akehurst, Racial Anne
Taylor, Anthony James
Wyatt, David Andrew
Taylor, Anthony James
Wyatt, David Andrew
Application Number:
JP51057492A
Publication Date:
March 27, 2000
Filing Date:
December 04, 1992
Export Citation:
Assignee:
GLAXO GROUP LTD.
International Classes:
A61K9/00; A61K9/12; A61K9/14; A61K9/72; A61K31/02; A61K31/135; A61K31/137; A61K9/127; A61K31/138; A61K31/167; A61K31/352; A61K31/44; A61K31/4402; A61K31/4458; A61K31/4535; A61K31/46; A61K31/4741; A61K31/48; A61K31/522; A61K31/56; A61K31/57; A61K31/573; A61K45/06; A61L9/04; A61M11/00; A61M15/00; A61P11/00; A61P11/06; A61P11/08; (IPC1-7): A61K31/137; A61K9/12; A61K9/72; A61K31/352; A61K31/44; A61K31/57; A61K47/06
Attorney, Agent or Firm:
Kazuo Shamoto (4 outside)